Лучшие больницы для «Pacemaker Implantation» в Мумбаи, Индия

The heart's electrical conduction system — comprising the sinoatrial (SA) node, atrioventricular (AV) node, His-Purkinje network, and ventricular myocardium — orchestrates the rhythmic contraction that sustains circulation. When intrinsic automaticity or conduction velocity falls below physiological thresholds, the result is bradycardia (typically defined as a resting heart rate below 40–50 beats per minute with symptoms), heart block (first-, second-, or third-degree), sick sinus syndrome, or chronotropic incompetence. These disorders manifest clinically as fatigue, exertional dyspnoea, pre-syncope, frank syncope (Stokes-Adams attacks), and — in severe cases — haemodynamic collapse. Risk stratification tools such as the EHRA Syncope Classification, ESC/ACC/AHA guideline-based Class I and IIa indications for pacing, and ambulatory monitoring data (Holter, implantable loop recorder) are used to confirm candidacy before any device is recommended.

• ELIGIBLE PATIENTS (Class I Indications per ACC/AHA/ESC):
• Symptomatic sinus node dysfunction (sick sinus syndrome, sinoatrial exit block) with documented bradycardia causing syncope, pre-syncope, or limiting fatigue
• Complete (third-degree) AV block regardless of symptoms, or second-degree Mobitz Type II AV block
• Chronic bifascicular or trifascicular block with intermittent complete AV block or symptomatic bradycardia
• Post-ablation heart block (following AV nodal ablation for atrial fibrillation with rapid ventricular response)
• +21 more

Standard Transvenous Pacemaker Implantation

The workhorse approach performed under local anaesthesia with conscious sedation. The pulse generator is implanted in a subcutaneous or submuscular pocket infraclavicularly (typically left-sided). Leads are advanced via the subclavian, axillary, or cephalic vein under fluoroscopic guidance to the right atrium (atrial lead tip at the right atrial appendage) and/or right ventricle (ventricular lead tip at the right ventricular apex or, preferably for physiological pacing, the His bundle or right ventricular outflow tract/septum). Pacing thresholds, sensing amplitudes, and impedance values are measured intra-operatively and must meet internationally accepted implant criteria before the pocket is closed.

Device TYPES AND SELECTION:

• Single-chamber pacemaker (VVI/VVIR or AAI/AAIR): indicated for chronic atrial fibrillation with bradycardia (ventricular lead only) or isolated sinus node dysfunction with intact AV conduction (atrial lead only)
• Dual-chamber pacemaker (DDD/DDDR): the most commonly implanted system; maintains AV synchrony, superior haemodynamics, and reduced pacemaker syndrome; indicated for AV block with preserved sinus function
• Biventricular pacemaker / Cardiac Resynchronisation Therapy (CRT-P): adds a coronary sinus lead to pace the left ventricle simultaneously, correcting interventricular dyssynchrony in heart failure; CRT-D combines resynchronisation with defibrillation capability
• His Bundle Pacing (HBP) and Left Bundle Branch Area Pacing (LBBAP): advanced physiological pacing strategies that capture the native conduction system, producing narrow QRS complexes and superior haemodynamic outcomes compared to conventional RV apical pacing; increasingly preferred in experienced electrophysiology centres for patients with AV block and normal LVEF
• Leadless Pacemaker (Micra AV, Abbott Aveir): catheter-delivered transcatheter device implanted directly into the right ventricular myocardium via femoral vein; no subcutaneous pocket, no transvenous leads; significantly lower risk of pocket haematoma, lead dislodgement, and device-pocket infection; indicated for patients with limited venous access, prior device infections, or high bleeding risk

PRE-ARRIVAL PHASE (4–6 weeks before travel):

• GAF Healthcare coordinator reviews existing medical records (ECGs, Holter reports, Echo, angiograms) and obtains a remote clinical opinion from the treating electrophysiologist
• Device type and surgical approach confirmed; estimated cost package issued
• e-Medical Visa (India) or UAE entry visa arranged; travel insurance with cardiac coverage advised
• Patient advised to continue anticoagulants per cardiologist guidance; aspirin/clopidogrel bridging protocol communicated

DAY 1 — Arrival AND Pre-operative ASSESSMENT: